Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye

BACKGROUND: Rebamipide with mucin secretagogue activity was recently approved for the treatment of dry eye. The efficacy and safety in the treatment of rebamipide were shown in two pivotal clinical trials. It was the aim of this study to evaluate the effect of 2 % rebamipide ophthalmic suspension in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Kaori, Matsumiya, Wataru, Otsuka, Keiko, Maeda, Yoshifumi, Nagai, Takayuki, Nakamura, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456696/
https://www.ncbi.nlm.nih.gov/pubmed/26048396
http://dx.doi.org/10.1186/s12886-015-0040-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456696/
https://www.ncbi.nlm.nih.gov/pubmed/26048396
http://dx.doi.org/10.1186/s12886-015-0040-0

Ejemplares similares